• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.

作者信息

Bonuccelli U, Piccini P, Marazziti D, Cassano G B, Muratorio A

机构信息

Institute of Clinical Neurology, University of Pisa, Italy.

出版信息

J Neural Transm Park Dis Dement Sect. 1990;2(2):139-47. doi: 10.1007/BF02260901.

DOI:10.1007/BF02260901
PMID:2222781
Abstract

Several biochemical abnormalities in peripheral tissues have been reported in Alzheimer's disease (AD). With this in mind we studied platelet monoamine oxidase B (MAO B) activity and 3H-imipramine (IMI) binding in both AD patients and healthy subjects and found a significantly higher level of platelet MAO B activity and 3H-IMI Bmax values in the AD patients. In view of the part that MAO B plays in metabolizing serotonin (5HT) and of the relationship which exists between 3H-IMI binding and 5HT uptake, our results would suggest that with AD there occurs a complex dysfunction in the 5HT system, at least at a peripheral level.

摘要

相似文献

1
Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
J Neural Transm Park Dis Dement Sect. 1990;2(2):139-47. doi: 10.1007/BF02260901.
2
Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.伴有激越和妄想的阿尔茨海默病患者血小板中氚标记丙咪嗪结合及单胺氧化酶活性
Psychiatry Res. 1988 Sep;25(3):311-22. doi: 10.1016/0165-1781(88)90101-1.
3
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.与未接受过5-羟色胺摄取抑制剂治疗的抑郁症患者血小板结合的[3H]-丙咪嗪的最大结合量降低。
Psychopharmacology (Berl). 1986;89(4):456-61. doi: 10.1007/BF02412121.
4
Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.阿尔茨海默型痴呆患者血小板中I2-咪唑啉受体与单胺氧化酶B活性之间的解离。
J Psychiatr Res. 1999 May-Jun;33(3):251-7. doi: 10.1016/s0022-3956(98)00065-x.
5
Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.阿尔茨海默病早期、中期和晚期女性患者的血小板血清素浓度及B型单胺氧化酶活性
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1226-31. doi: 10.1016/j.pnpbp.2009.07.004. Epub 2009 Jul 12.
6
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.血小板3H-丙咪嗪结合可区分抑郁症与阿尔茨海默病性痴呆。
Life Sci. 1985 Dec 16;37(24):2305-11. doi: 10.1016/0024-3205(85)90022-0.
7
Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.对健康志愿者进行短期锂给药会使血小板5-羟色胺摄取产生持久而显著的变化,但对丙咪嗪结合无此影响。
Psychopharmacology (Berl). 1988;94(4):521-6. doi: 10.1007/BF00212848.
8
Platelet markers in suicide attempters.
Prog Neuropsychopharmacol Biol Psychiatry. 1995 May;19(3):375-83. doi: 10.1016/0278-5846(95)00019-r.
9
Methodological issues in the preparation and assay of platelet 3H-imipramine binding.血小板3H-丙咪嗪结合物制备与测定中的方法学问题。
Psychiatry Res. 1990 Jul;33(1):19-29. doi: 10.1016/0165-1781(90)90145-u.
10
Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.比较血小板蛋白质组分析显示,阿尔茨海默病患者中单胺氧化酶-B 蛋白表达增加,而未痴呆的帕金森病患者中则没有。
J Proteomics. 2012 Apr 3;75(7):2080-92. doi: 10.1016/j.jprot.2012.01.014. Epub 2012 Jan 17.

引用本文的文献

1
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?血小板,外周阿尔茨海默病生物标志物的可靠来源?
Acta Neuropathol Commun. 2014 Jun 16;2:65. doi: 10.1186/2051-5960-2-65.